Phapros is Optimistic to Achieve Double-Digit Growth in 2023.

Jakarta, January 11, 2022 - PT Phapros Tbk, which is one of the members of the state-owned pharmaceutical holding, is optimistic about achieving double-digit growth in 2023. The growth will mainly be driven by the development and innovation of new products.

The President Director of Phapros, Hadi Kardoko, stated that in the midst of the current tight competition in the pharmaceutical industry, innovation is the key to survival. "Throughout 2022, we have launched thirteen products together with our subsidiary, PT Lucas Djaja Group. These thirteen products are the result of development and research that are also aligned with the needs of the community," he said.

In 2023, the stock-coded company PEHA is also planning to launch ten to twelve new products that are expected to drive the company's performance to meet its targets.

"The new products to be launched come from several therapeutic classes, including antibiotics, multivitamins, and products from other therapeutic classes that are included in the first line therapy, thus adding to the product range of PT Phapros Tbk," explained Hadi. He also added that by 2023, Phapros' new product portfolio will consist of 60% branded and 40% generic products.

In addition, Phapros is also collaborating with Airlangga University and Dr. Soetomo Regional Hospital, Surabaya to develop bone and dental medical devices. The research will be carried out through technology transfer to Phapros' own medical device production facility. In 2023, Phapros will also rebrand its over-the-counter products, as well as implement other strategies.

Previously, in 2022, Phapros launched Curlysine, a food supplement for children with a combination of curcumin extract, lysine, and taurine, which is intended to improve children's appetite, prevent stunting, and act as an immunomodulator. In the same year, the PEHA-coded company also realized the sale of 500 million Blood Boosting Tablets throughout Indonesia as evidence of Phapros' commitment to fighting stunting.